Valuation: Imexpharm Corporation

Market Cap 6,422B 244M 214M 198M 183M 346M 23.39B 353M 2.38B 924M 11.44B 917M 897M 39.73B P/E 2026 *
18.1x
P/E 2027 * 16.7x
Enterprise Value 6,422B 244M 214M 198M 183M 346M 23.39B 353M 2.38B 924M 11.44B 917M 897M 39.73B EV / Sales 2026 *
2.42x
EV / Sales 2027 * 2.23x
Free-Float
6.42%
Yield 2026 *
2.4%
Yield 2027 * 2.4%
1 day-0.24%
1 week-0.24%
Current month+1.21%
1 month-8.95%
3 months-25.00%
6 months-20.57%
Current year-20.57%
1 week 41,500
Extreme 41500
43,150
1 month 41,100
Extreme 41100
46,300
Current year 41,100
Extreme 41100
57,000
1 year 41,100
Extreme 41100
57,000
3 years 23,681.82
Extreme 23681.8182
57,000
5 years 18,831.17
Extreme 18831.1688
57,000
10 years 12,503.97
Extreme 12503.9651
57,000
Manager TitleAgeSince
Chief Executive Officer 74 31/07/2001
Director of Finance/CFO 52 17/01/2024
Chief Operating Officer 47 -
Director TitleAgeSince
Chairman 74 31/12/1983
Director/Board Member 50 27/04/2018
Director/Board Member 53 18/12/2023
Date Insider Type Main position Quantity % Market Cap.
25/09/22Buy

Chief Executive Officer

140,000 0.2100%
19/07/22Sell

Chief Executive Officer

100,000 0.1500%
31/03/22Fiscal year

Chairman

50,000 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%-0.24%-20.11%+50.75% 244M
-1.60%+2.02%+56.34%+168.94% 1,084B
-1.44%+3.71%+69.07%+65.40% 634B
-0.75%+0.67%+33.18%+86.52% 447B
-0.18%-2.17%+28.50%+25.96% 330B
-8.69%-10.39%+25.73%+27.98% 295B
-0.44%-2.16%+28.41%+46.02% 285B
-0.81%-3.46%-27.66%-39.63% 218B
-0.03%+1.84%+23.90%+68.30% 199B
-0.40%+7.82%+22.29%+82.50% 169B
Average -1.24%+2.04%+23.97%+58.27% 366.01B
Weighted average by Cap. -1.11%+2.48%+40.23%+85.25%

Financials

2026 *2027 *
Net sales 2,659B 101M 88.7M 81.89M 75.67M 143M 9.68B 146M 984M 382M 4.74B 380M 371M 16.45B 2,881B 110M 96.1M 88.72M 81.99M 155M 10.49B 159M 1.07B 414M 5.13B 411M 402M 17.82B
Net income 394B 14.98M 13.14M 12.13M 11.21M 21.25M 1.43B 21.68M 146M 56.68M 702M 56.27M 55.04M 2.44B 428B 16.28M 14.28M 13.18M 12.18M 23.09M 1.56B 23.55M 158M 61.57M 763M 61.13M 59.79M 2.65B
Net Debt - -
Logo Imexpharm Corporation
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
Employees
1,444
Date Price Change Volume
08/07/26 ₫41,700.00 -0.24% 1,204
07/07/26 ₫41,800.00 -2.56% 6,102
06/07/26 ₫42,900.00 -0.12% 15,834
03/07/26 ₫42,950.00 +0.59% 13,451
02/07/26 ₫42,700.00 +2.15% 5,482
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
41,700.00VND
Average target price
56,000.00VND
Spread / Average Target
+34.29%

Annual profits - Rate of surprise